Background: To date, no crossover studies have compared the effects of high-protein (HP) and low glycemic index (LGI) diets applied as starting energy-restricted diets.
Methods: Thirty-five overweight or obese volunteers with sedentary lifestyles aged 41.4 ± 11.
Introduction: A high level of uric acid (UA) is a strong, independent risk factor for type 2 diabetes mellitus. The relationship between UA levels and the development of type 2 diabetes in women with previous gestational diabetes mellitus (pGDM) remains unclear. The aim of study was to evaluate the UA levels in pGDM women in relation to their current nutritional status and carbohydrate metabolism.
View Article and Find Full Text PDFDiabetol Metab Syndr
October 2015
Background: Previous gestational diabetes (pGDM) is a risk factor of type 2 diabetes, hypertension and cardiovascular diseases. Homocysteine is one of markers of cardiovascular risk. The aim of this study was to assess the homocysteine levels in women with pGDM and to evaluate its relationship with current carbohydrate metabolism and nourishment status.
View Article and Find Full Text PDFIntroduction: An increased risk of developing type 2 diabetes in women with a history of gestational diabetes mellitus(gestational diabetes mellitus - GDM) may be associated with increased insulin resistance and subclinical inflammation. However, approximately half of women with previous GDM (pGDM) do not develop diabetes. These women were the population of focus in the present study.
View Article and Find Full Text PDFBackground: Gestational diabetes mellitus (GDM) is associated with health consequences for both, the mother and her offspring. In Poland, the diagnosis of GDM is based on the recommendations of the Polish Gynecological Society (PTG) and is usually made by obstetricians.
Objective: The aim of the study was to assess practical implementation of PTG standards of GDM screening and diagnosis.
The purpose of this study was to assess the concentration of C-reactive protein (CRP) in obese type 2 diabetes mellitus (DM2) patients and its association with macrovascular and microvascular complications. The study group consisted of 80 obese DM2 patients, including 20 macrovascular, 20 microvascular, 20 both macrovascular and microvascular, and 20 with no complications patients. The control group comprised 40 normoglycemic subjects--20 obese and 20 of normal body weight.
View Article and Find Full Text PDFExp Diabetes Res
December 2012
Aim: The aim of this study is to investigate the relationship between the common C49620T polymorphism in the sulfonylurea receptor (SUR1) gene and glucose metabolism, β-cell secretory function and insulin resistance in women with a history of gestational diabetes (GDM).
Material And Methods: Study group included 199 women, diagnosed GDM within the last 5-12 years and control group of comparable 50 women in whom GDM was excluded during pregnancy. Blood glucose and insulin levels were measured during oral glucose tolerance test.
Disorders of gluconeogenesis and fatty acid oxidation disorders belong to rare causes of hypoglycemia. Most of them are diagnosed in a childhood, but they can be revealed also in an adulthood. This paper discusses clinical and laboratory signs of these disorders and presents cases of patients diagnosed in adulthood and described in the literature.
View Article and Find Full Text PDFPol Merkur Lekarski
February 2011
Metabolic diseases such as glycogen storage diseases, disorders of gluconeogenesis and fatty acid oxidation disorders belong to rare causes of hypoglycemia. Most of them are diagnosed in a childhood, but they can be also revealed in an adulthood. This paper discusses clinical and laboratory signs of glycogen storage diseases leading to hypoglycemia.
View Article and Find Full Text PDFDiabetic nephropathy is a leading cause of end-stage renal disease. In this paper the role of renin-angiotensin-aldosterone system (RAA) in the pathogenesis of diabetic nephropathy is discussed and clinical effects of multilevel pharmacological blockade of RAA system by combined treatment with ACE inhibitors, angiotensin receptor blockers (ARB) and aldosterone antagonists is described.
View Article and Find Full Text PDF